Compare CDE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDE | DGX |
|---|---|---|
| Founded | 1928 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 21.0B |
| IPO Year | 1994 | 1996 |
| Metric | CDE | DGX |
|---|---|---|
| Price | $19.22 | $195.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $22.40 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 17.1M | 635.0K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | ★ 533.33 | 13.78 |
| EPS | 0.35 | ★ 2.24 |
| Revenue | $709,598,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $165.39 | $7.53 |
| Revenue Next Year | $12.10 | $3.77 |
| P/E Ratio | ★ $53.19 | $87.84 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $8.26 | $164.65 |
| 52 Week High | $27.77 | $213.50 |
| Indicator | CDE | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 55.29 |
| Support Level | $19.08 | $191.75 |
| Resistance Level | $20.06 | $200.49 |
| Average True Range (ATR) | 0.93 | 3.64 |
| MACD | 0.11 | 0.86 |
| Stochastic Oscillator | 66.45 | 83.27 |
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.